Please know that during this challenging time of COVID-19, we are taking all measures to ensure the safety, health, and wellness of our employees and customers, which is our top priority. We also remain fully committed to achieving our clients' goals, and with a robust continuity plan in place, we stand ready and able to assist you in any way we can. Thank you for your continued partnership. 

RAPS webcast

Achieving Regulatory Success

As Certara's Regulatory Science Division, Synchrogenix accelerates the regulatory submissions of medical innovations worldwide through customized regulatory solutions, including strategy, communications, operations and technology.

Customized Regulatory Solutions Backed by A Proven Record of Success

Learn More

Increase your product's chance of expedited approval and greater patient access with global program development guidance from seasoned experts. More.

Learn More

Communicate with confidence beside a strategic partner who has the knowledgeable professionals and depth of expertise your scientific investment deserves. More.

Learn More

Streamline your electronic submissions and file on time, if not sooner with dedicated publishing teams who are scalable and provide visibility throughout the entire process. More.

Learn More

Advance your drug approvals utilizing the industry’s leading-edge technologies for writing and content reuse, submissions management, and transparency and disclosure. More.

Interested in Synchrogenix?

  Contact Us